Medicare Enrolled

Dr. Roberto Saenz, OD

Corneal and Contact Management Optometrist · San Antonio, TX
Speaking/Promotional
23103 IH 10 W STE 105, San Antonio, TX 78257
2102102020
In practice since 2016 (9 years)
NPI: 1821440280 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Saenz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saenz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Saenz

Dr. Roberto Saenz is a corneal and contact management optometrist in San Antonio, TX, with 9 years of NPI registration.

Between the years covered by Open Payments, Dr. Saenz received a total of $159,244 from 41 pharmaceutical and/or device companies across 375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in corneal and contact management optometrist. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Saenz is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice $159,244 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$159,244
Total received (2018-2024)
Avg $22,749/year across 7 years
Top 1% in TX for corneal and contact management optometrist
41
Companies
375
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99,857 (62.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$53,819 (33.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,568 (3.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,194
2023
$59,285
2022
$26,190
2021
$25,577
2020
$16,643
2019
$23,236
2018
$2,119

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$35,613
Oyster Point Pharma, Inc.
$18,040
BIOTISSUE HOLDINGS, INC.
$17,979
Sight Sciences, Inc.
$16,760
Johnson & Johnson Surgical Vision, Inc.
$11,022
Carl Zeiss Meditec, Inc.
$10,563
Allergan, Inc.
$9,647
GLAUKOS CORPORATION
$7,782
Kala Pharmaceuticals, Inc.
$5,954
LENSAR, Inc.
$5,696
TissueTech, Inc.
$3,200
TISSUETECH, INC.
$2,795
ABBVIE INC.
$2,282
NOVARTIS PHARMACEUTICALS CORPORATION
$1,851
Alcon Vision LLC
$1,711
Quidel Corporation
$1,415
Horizon Therapeutics plc
$1,213
AbbVie Inc.
$1,176
BIOTISSUE HOLDINGS INC.
$1,000
Shire North American Group Inc
$442
RxSight Inc
$421
Bausch & Lomb, a division of Bausch Health US, LLC
$354
Tarsus Pharmaceuticals, Inc.
$294
Novartis Pharmaceuticals Corporation
$293
Lumenis, Inc
$267
STAAR SURGICAL COMPANY
$214
BioTissue Holdings, Inc.
$210
Carl Zeiss Meditec USA, Inc.
$188
Allergan Inc.
$170
Sun Pharmaceutical Industries Inc.
$165
EMD Serono, Inc.
$118
Johnson & Johnson Vision Care, Inc.
$100
Bausch & Lomb Americas Inc.
$67
Dompe US, Inc.
$45
SUN PHARMACEUTICAL INDUSTRIES INC.
$42
Alcon Laboratories Inc
$40
Ocular Therapeutix, Inc.
$37
Thea Pharma Inc.
$22
Mallinckrodt Hospital Products Inc.
$21
NovaBay Pharmaceuticals, Inc.
$19
Oasis Medical, Inc.
$16
Top 3 companies account for 45.0% of total payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · ARGOS · AcrySof · AcrySof IQ PanOptix · AcrySof IQ VIVITY IOL · Avenova · CATALYS SYSTEM · CE-marked KXLA system · CEQUA · CIRRUS 5000 · CIRRUS 6000 · CIRRUS HD-OCT · Catalys Laser System · Centurion · Cequa · Clareon · DEXTENZA · DURYSTA · EYSUVIS · Eye Health · IACCESS · IC-8 Apthera IOL · ILINK · INVELTYS · IOL · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · KXL System · KXL system (not refurbished) · LENSAR LASER SYSTEM · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX GEL · LOTEMAX SM · LUMERA 700 · LUMIGAN · NEOX · None Specified · OASIS TEARS · OMNI · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · OZURDEX · One Series Ultra · PROKERA · PanOptix · Phacofragmentation Accessories · Photrexa · Prokera · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · RXSIGHT INJECTOR HANDPIECE · ReSTOR · ReSure Sealant · STAR S4 IR Excimer Laser System · TEARCARE SYSTEM · TECNIS IOL · TEPEZZA · TYRVAYA · TearCare · TearCare SmartLid · TearScience Lipiflow System · TearScience Lipiscan System · TearScience Lipiview System · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · VUITY · VYZULTA · VisuMax · Wavelight · Wavelight Refractive Suite · Whitestar Phacoemulsficiation System · XDEMVY · XELPROS · XIIDRA · ZYLET · iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM · iStent · iStent Trabecular Micro-Bypass Stent System · iStent Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · iStent inject Trabecular Micro-Bypass System Model G2-M-IS · iStent inject W
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (63%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in corneal and contact management optometrist and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for corneal and contact management optometrist in TX.

Looking for a corneal and contact management optometrist in San Antonio?
Compare corneal and contact management optometrists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse corneal and contact management optometrists nearby

Geographic Context

Corneal and contact management optometrists within 10 mi
9
Per 100K population
0.4
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
5.6 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Saenz is a corneal and contact management optometrist, with speaking/promotional industry engagement in the top 1% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Saenz receive payments from pharmaceutical companies?
Yes. Dr. Saenz received a total of $159,244 from 41 companies across 375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Saenz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Corneal And Contact Management Optometrists in San Antonio
Browse corneal and contact management optometrists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Corneal And Contact Management Optometrists in TX
Corneal and contact management optometrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Corneal And Contact Management Optometrists in TX
Which TX corneal and contact management optometrists receive the most from drug and device companies.
By company
Glaukos Corporation Payments to Doctors
See all physicians who received payments from Glaukos Corporation.
By company
Oyster Point Pharma, Inc. Payments to Doctors
See all physicians who received payments from Oyster Point Pharma, Inc.
By company
BIOTISSUE HOLDINGS, INC. Payments to Doctors
See all physicians who received payments from BIOTISSUE HOLDINGS, INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →